Sodium Phosphates Injection, Solution
Product Images NDC 63323-884

This appears to be a product label for a Sodium Phosphates injection that is sterile and non-pyrogenic. The ingredients and dosage are listed, as well as storage instructions and cautions that it must be diluted and is for intravenous use only. The product is preservative-free and manufactured by Fresenius Kabi.*

Sodium Phosphates Injection, USP is a sterile, non-pyrogenic medication typically used intravenously. Each 5 mL single-dose vial contains Monobasic sodium phosphate, monohydrate 276mg and dibasic sodium phosphate, anhydrous 142mg equivalent to 268 mg dibasic sodium phosphate, heptahydrate. The solution is preserved free and must be diluted before use. The use and dosages of this medication should follow the package insert. The container closure is not made with natural rubber latex. It is produced by Fresenius Kabi in Lake Zurich, IL.*

Sodium Phosphates Injection, USP is a solution for Intravenous use. It must be diluted before use and is preservative-free. Each mL contains Monobasic sodium phosphate, monohydrate 276 mg, and dibasic sodium phosphate, anhydrous 142 mg. This medication has a usual dosage which can be found in the package insert. The injection contains no more than 180 mcg/Liter of aluminum and should be stored at 20° to 25°C (68° to 77°F) which is a controlled room temperature according to the USP. The manufacturer is Fresenius Kabi located in Lake Zurich, IL 60047.*

This is a description of an injectable solution containing sodium phosphates. Each 15 mL vial contains 45 mM P and 60 mEqg Na. It must be diluted before use. It is sterile, non-pyrogenic, and preservative-free. The solution contains no bacteriostat, and must be used promptly after addition to the IV solution. It should be stored at 20-25°C. The container closure is not made with natural rubber latex. The usual dosage is mentioned in the package insert, and the stopper must be cleaned with an antiseptic before use.*

This is a description of a pharmaceutical product called Sodium Phosphates. It comes in a 50 mL single dose vial which contains 150 mM per 50 mL of P and 200 mEg per 50 mL of Na*. It is intended for intravenous use and does not contain preservatives. It must be diluted before use. It is sterile, nonpyrogenic, and contains a specific amount of Monobasic sodium phosphate, monohydrate, and dibasic sodium phosphate, anhydrous. It does not contain more than 180 mcg/Liter of aluminum. The storage temperature recommended is between 20° to 25°C (68° to 77°F), and the unused portion must be discarded. There is no readable information on the Lot/Exp code.*

NDC 63323-886-56 is an injection solution of sodium and phosphates. It contains 150 mM P per 50 mL and 200 mEq Na*per 50 mL. It must be diluted before intravenous use and is preservative-free. It comes as 25 x 50 mL single-dose vials that are sterile, nonpyrogenic. The solution is made up of Monobasic sodium phosphate, monohydrate 276 mg and dibasic sodium phosphate, anhydrous 142 mg (equivalent to 268 mg dibasic sodium phosphate, heptahydrate). The container closure is not made with natural rubber latex. It is recommended to use after carefully reading the package insert. There are specific instructions for use, and those who use it must check that the seal is intact and undamaged. It should be cleansed with an antiseptic before IV addition, and it should be added to a suitable IV solution aseptically. There is no bacteriostat, and the unused potion must be discarded promptly. The solution should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].*